Health Companies' Momentum May Cut Right Through Reform Savings

Main Category: Health Insurance / Medical Insurance
Also Included In: Pharma Industry / Biotech Industry;  Medicare / Medicaid / SCHIP
Article Date: 26 Nov 2009 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:1 star

1 (1 votes)

Healthcare Prof:not yet rated

Health companies have done better than the rest of corporate America during the past decade, MarketWatch/Seattle Times reports. While profits at the S&P 500 companies declined slightly over 10 years, "[d]ata compiled by MarketWatch show that the 52 health-care companies in the index are about to close out the decade with average profits that nearly tripled." Despite Congress' efforts to overhaul the health system, analysts say "that level of moneymaking seems unlikely to change anytime soon" because "there just aren't many reform proposals that would take a significant bite out of health-care profits (Britt, 11/25).

With that in mind, lawmakers have been eyeing the pharmaceutical industry, PharmExec reports. "Congressional leaders clearly believe that pharmaceutical companies can afford to contribute more than $80 billion [already committed] to support health reform … [in part because] the boost in coverage to some 40 million potential customers is a 'sweetheart deal' that will increase sales more than enough to cover those losses." House Democrats are considering a bill that could allow the government to negotiate for Medicare drug prices for the first time, costing the industry another $40 billion over 10 years (Wechsler, 11/24).

Meanwhile, new research suggests another possible pricing controversy. "Medicaid pharmacy costs for the blood-thinning drug Plavix jumped at around the same time the drug's maker started advertising it to consumers -- even though the number of people prescribed the drug didn't change," a study in the Archives of Internal Medicine suggests, ABC News reports (Harding, 11/24).

This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

© Henry J. Kaiser Family Foundation. All rights reserved.



View drug information on Plavix.


Article adapted by Medical News Today from original press release.
Visit our health insurance / medical insurance section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "Health Companies' Momentum May Cut Right Through Reform Savings." Medical News Today. MediLexicon, Intl., 26 Nov. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/172255.php>

APA
Kaiser. (2009, November 26). "Health Companies' Momentum May Cut Right Through Reform Savings." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/172255.php.

Please note: If no author information is provided, the source is cited instead.


Health Insurance / Medical Insurance

Most Popular Articles



Follow Our Health Insurance News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Health Insurance / Medical Insurance Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »